Brief report: physicians and their personal prostate cancer-screening practices with prostate-specific antigen. A national survey.

Journal of General Internal Medicine
Evelyn C Y ChanChul Ahn

Abstract

There is inconclusive evidence that prostate cancer screening with prostate-specific antigen (PSA) reduces mortality. Although PSA testing is widespread, it is unknown how many physicians have taken the PSA test themselves. To determine the prevalence of PSA testing among physicians. Cross-sectional survey. A nationwide stratified random sample of urologists (response rate 61%, n=247), Internists (response rate 51%, n=273), and family physicians (response rate 64%, n=249) were surveyed by mail in 2000. After excluding female respondents and men who either reported a positive history of prostate cancer or did not respond to that query, there were 146 urologists, 96 Internists, and 118 family physicians. Whether physicians had undergone prostate cancer screening with PSA. Eighty-seven percent (155/178) of male physicians aged, 50 and older and 21% (31/150) of white male physicians under age 50 reported having had a PSA test. More urologists than nonurologists in both age groups reported having had a screening PSA test. Most physicians aged 50 and older report undergoing PSA testing. This may reflect a belief in its efficacy and contribute to its widespread use.

References

Nov 9, 2000·Urology·L A KalishJ B McKinlay
Mar 21, 2002·Journal of General Internal Medicine·J D Voss, J M Schectman
May 29, 2002·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Scott B CantorStephen J Spann
Dec 3, 2002·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
Mar 15, 2003·JAMA : the Journal of the American Medical Association·Brenda E SirovichSteven Woloshin
Jun 11, 2003·Journal of General Internal Medicine·Evelyn C Y ChanChul Ahn
Jun 15, 2004·Preventive Medicine·Louie E RossDonald Blackman

❮ Previous
Next ❯

Citations

Mar 20, 2009·The New England Journal of Medicine·Michael J Barry
Mar 30, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael W DrazerScott E Eggener
May 5, 2012·Psychological Science·Hal R Arkes, Wolfgang Gaissmaier
Apr 2, 2008·The Oncologist·Stacy Loeb, William J Catalona
Nov 21, 2013·Experimental and Therapeutic Medicine·Bin LiuHai-Cheng Gao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Cancer. Journal International Du Cancer
Harry J de KoningInternational Prostate Cancer Screening Trials Evaluation Group
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
R Postma, Fritz H Schröder
BMJ : British Medical Journal
N Mays, C Pope
© 2022 Meta ULC. All rights reserved